TY  - CHAP
AU  - Liming Shen
AU  - Sijian Xia
AU  - Huajie Zhang
AU  - Fang Yao
AU  - Xukun Liu
AU  - Yuxi Zhao
AU  - Ming Ying
AU  - Javed Iqbal
AU  - Qiong Liu
ED  - Sinem Nalbantoglu
ED  - Hakima Amri
Y1  - 2018-11-19
PY  - 2018
T1  - Precision Medicine: Role of Biomarkers in Early Prediction and Diagnosis of Alzheimer’s Disease
N2  - Molecular medicine is an applied science focused on human genes/transcripts, proteins, metabolites, and metabolic networks that describes molecular and cellular processes of health and disease onset and progression. Molecular medicine-based integrative identification and characterization of biomarker targets and their clinical translations is essential to explain/decipher the mechanism(s) underlying physiological pathways and pathological conditions, and acquire cell-targeted early interventional and therapeutic strategies in the context of precision medicine and public health.  Principally, Molecular Medicine provides an overview of the latest headlines/developments of systems and molecular medicine, highlighting the emerging high-throughput technologies, promising potential applications, and progress in biomedical research and development strategies.
BT  - Molecular Medicine
SP  - Ch. 2
UR  - https://doi.org/10.5772/intechopen.82035
DO  - 10.5772/intechopen.82035
SN  - 978-1-83962-760-6
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-26
ER  -